VERIFIEDET Finance·4 Jul 2026neutral

Sun Pharma secures relief in 'Pantocid' trademark dispute

AI Summary

·Delhi High Court has stopped Finecure Pharmaceuticals from selling drugs with names similar to Sun Pharma's 'Pantocid'.
·Finecure Pharmaceuticals is allowed to sell existing stock of 'Pantopacid' within four months after filing an inventory affidavit.
·The court's decision reverses a prior ruling that had denied an injunction against Finecure.